This article is more than 5 years old. Information may no longer be current.
Solar eclipse, ASRS meeting top retina news
Click Here to Manage Email Alerts
News of the solar eclipse that crossed the United States led retina-based ophthalmology news in the month of August, with coverage from the American Society of Retina Specialists meeting coming close behind.
Here are August’s four most read retina stories on Healio.com/OSN:
1. Staring at eclipse may cause solar retinopathy
Remember when you were a kid and you used a magnifying glass to concentrate the sun’s energy to burn paper? Solar retinopathy is like that except it is the fovea that is getting burned, according to one expert. Read more here.
2. Long-term anti-VEGF therapy maintains visual improvements
Long-term treat-and-extend anti-VEGF therapy maintains vision in some patients, even after 8 years and more than 50 injections, according to a study presented at ASRS. Read more here.
3. Fewer anti-VEGF injections needed over time
A real-world look at the treat-and-extend regimen of anti-VEGF agents for treating neovascular age-related macular degeneration showed improved vision in patients with fewer injections per year. Read more here.
4. AGTC files investigational NDA for X-linked retinitis pigmentosa gene therapy
Applied Genetic Technologies Corporation has filed an investigational new drug application with the FDA to begin a phase 1/2 clinical trial of its gene therapy candidate for X-linked retinitis pigmentosa. Read more here.